TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $464 | -85.8% | 55,545 | -57.8% | 0.00% | -75.0% |
| Q2 2023 | $3,266 | +210.5% | 131,479 | +88.0% | 0.00% | +300.0% |
| Q1 2023 | $1,052 | -3.8% | 69,937 | -24.4% | 0.00% | 0.0% |
| Q4 2022 | $1,094 | -99.8% | 92,451 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $548,000 | +39.8% | 92,535 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $392,000 | -55.4% | 92,214 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $879,000 | -50.0% | 92,392 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $1,759,000 | -59.3% | 92,595 | -28.7% | 0.00% | -60.0% |
| Q3 2021 | $4,323,000 | -27.7% | 129,901 | -15.7% | 0.01% | -16.7% |
| Q2 2021 | $5,976,000 | -1.0% | 154,066 | +23.0% | 0.01% | -14.3% |
| Q1 2021 | $6,036,000 | -15.0% | 125,229 | -8.3% | 0.01% | -12.5% |
| Q4 2020 | $7,102,000 | +180.8% | 136,518 | +44.5% | 0.01% | +166.7% |
| Q3 2020 | $2,529,000 | +46.7% | 94,500 | +6.8% | 0.00% | +50.0% |
| Q2 2020 | $1,724,000 | +126.0% | 88,500 | +14.2% | 0.00% | +100.0% |
| Q1 2020 | $763,000 | -11.3% | 77,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $860,000 | +90.3% | 77,500 | -3.7% | 0.00% | 0.0% |
| Q3 2019 | $452,000 | -35.2% | 80,500 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $697,000 | +37.5% | 80,600 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $507,000 | +168.3% | 63,100 | +37.2% | 0.00% | – |
| Q4 2018 | $189,000 | -48.6% | 46,000 | -30.1% | 0.00% | – |
| Q3 2018 | $368,000 | -57.5% | 65,800 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $865,000 | -41.2% | 65,800 | -36.5% | 0.00% | -50.0% |
| Q1 2018 | $1,472,000 | +74.6% | 103,653 | +0.8% | 0.00% | +100.0% |
| Q4 2017 | $843,000 | -30.8% | 102,853 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,219,000 | +17.9% | 102,853 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,034,000 | -61.8% | 102,853 | -55.8% | 0.00% | -75.0% |
| Q1 2017 | $2,710,000 | +160.3% | 232,652 | +3.9% | 0.00% | +300.0% |
| Q4 2016 | $1,041,000 | -39.9% | 223,851 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,733,000 | +27.7% | 223,851 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,357,000 | -28.8% | 223,851 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $1,907,000 | -28.6% | 223,851 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $2,671,000 | +46.4% | 223,851 | +23.7% | 0.00% | +33.3% |
| Q3 2015 | $1,824,000 | -40.0% | 180,918 | -1.2% | 0.00% | -25.0% |
| Q2 2015 | $3,039,000 | -24.1% | 183,168 | -29.2% | 0.00% | -33.3% |
| Q1 2015 | $4,006,000 | +74.2% | 258,789 | +78.3% | 0.01% | +100.0% |
| Q4 2014 | $2,300,000 | – | 145,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |